Category: Clinical Trial
Two New Trials Now Enrolling Aim to Expand Use of Focused Ultrasound Technology to Treat Cancer and Its Side Effects
Find out if your patients may be candidates for two studies now enrolling for solid tumors and pain resulting from head and neck cancer.
New Understanding of Racial Disparities in Colon Cancer May Lead to a Path to Prevention
With support from a National Cancer Institute Cancer Disparities SPORE P20 Planning Grant for research, UVA family physician and researcher Li Li, MD, and his team launched a study to find out how the colon ages and why African Americans are at increased risk for the more deadly right-side colon cancer.
Mitral Valve Regurgitation: Studies Now Enrolling at UVA
As a renowned heart center that excels in valve surgery, UVA has taken significant steps over the past decade to find alternative solutions to make treatment for mitral valve regurgitation safer, easier and more effective.
UVA Now Offering Focused Ultrasound Trial for Glioblastoma Patients
Focused ultrasound temporarily opens the blood-brain barrier to allow the delivery of more cancer-fighting agent to the tumor.
Now Enrolling: Heart & Vascular Clinical Trials
View a list of trials now enrolling at UVA Heart & Vascular Center.
Two New Studies Now Enrolling at UVA
Learn more about the SALT Study and a trial focusing on developing a sentinel lymph node mapping (SLNm) technique for patients with early-stage rectal cancer.
With a Growing Team of Physician-Scientists, UVA Is Increasing Immunotherapy Trials for Cancer
An expert in immunotherapy, Lawrence G. Lum, MD, DSc joins UVA Cancer Center as the scientific director of bone marrow transplantation. One of Lum’s priorities is pioneering a new method of activating the body’s own T cells to target tumor cells.
New Trial for High-Grade Gliomas Now Enrolling
High-grade glioma patients at UVA now have the opportunity to participate in Toca 5, an international clinical trial of a new, virus-based procedure that activates therapeutics selectively within the brain tumor, leading to fewer side effects.
Have Your Patients Considered Precision Breast IORT?
Precision Breast IORT is a unique form of IORT developed at UVA — now being examined in a Phase II clinical trial — that incorporates CT imaging and high-dose rate (HDR) brachytherapy.
Two New Studies for End-Stage Heart Failure
Find out if your patients are eligible for the next-generation LVAD treatment or novel stem cell therapy, now being examined by leading heart specialists at UVA.